Academician Changxiao Liu established China's first pharmacokinetic research laboratory, which was the predecessor of the Tiancheng’s Pharmacokinetic Research Center.
1987
The pharmacological research team from the three affiliated institutions of the National Medical Administration - Beijing Medical Institute, Tianjin Medical Institute, and Tianjin Institute of Traditional Chinese Medicine - formed the Pharmacology Department of the Tianjin Institute of Pharmaceutical Research under the National Medical Administration.
1993
The first ministerial level key laboratory under the National Medical Administration, the "Tianjin Hypertension Pharmacodynamics Laboratory," was established as one of the predecessors of the Tiancheng’s Pharmacodynamics Research Center.
1993
Participated in drafting the first drug safety evaluation research standard for Non-clinical Drug Research in China.
1995
The Key Laboratory of Pharmacokinetics and Clinical Pharmacology of the New Drug Research and Management Center of the National Medical Administration has been approved for establishment.
1997
The New Drug Safety Evaluation Research Center of Tianjin Pharmaceutical Research Institute was established.
2002
The Tianjin Pharmaceutical Research Institute New Drug Preclinical Evaluation Research Center was established.
2003
The Ministry of Science and Technology approved the establishment of the "Tianjin Pharmacokinetics and Pharmacodynamics Provincial Key Laboratory".
2005
Registered and established the legal entity "Tianjin New Drug Safety Evaluation Research Center" (later renamed as: Tianjin Tiancheng Drug Assessment Research Co., Ltd.).
2007
Obtained GLP certification for the first time.
2010
The State Key Laboratory of Drug Release Technology and Pharmacokinetics of the Ministry of Science and Technology was approved to be established.
2011
The new site of Binhai High-tech industrial development area was put into use.
2013
Obtained AAALAC certification for the first time.
2013
Began preclinical research on cell drugs and participate in major national science and technology projects for cell therapy.
2016
Obtained national recognition as a "high-tech enterprise" for the first time.
2017
Established the common key technology platform for stem cell product evaluation.
2018
Joined China Merchants Group.
2020
Renamed as Tianjin Tiancheng Drug Assessment Research Co., Ltd.
2022
Obtained CNAS certification for the first time.
Tianjin Tiancheng Drug Assessment Research Co.,Ltd.
Address:No.308,Huiren Avenue,Binhai Science and Technology Park,Binhai High-Tech Industrial Development Area,Tianjin
